This article has been cited by
1Inhibition of prostate cancer growth by solanine requires the suppression of cell cycle proteins and the activation of ROS/P38 signaling pathway
Bin Pan,Weifeng Zhong,Zhihai Deng,Caiyong Lai,Jing Chu,Genlong Jiao,Junfeng Liu,Qizhao Zhou
Cancer Medicine.2016;5(11)3214
[DOI]
2IKK inhibitor suppresses epithelial-mesenchymal transition and induces cell death in prostate cancer
Hao Ping,Feiya Yang,Mingshuai Wang,Yinong Niu,Nianzeng Xing
Oncology Reports.2016;36(3)1658
[DOI]
3IKK inhibitor suppresses epithelial-mesenchymal transition and induces cell death in prostate cancer
Harun Badakhshi
Oncology Reports.2017;36(3)163
[DOI]
4IGHG1 Regulates Prostate Cancer Growth via the MEK/ERK/c-Myc Pathway
Jing Chu,Yutong Li,Zhihai Deng,Zhenlin Zhang,Qun Xie,Heyuan Zhang,Weifeng Zhong,Bin Pan
BioMed Research International.2019;2019(3)1
[DOI]
5IGHG1 Regulates Prostate Cancer Growth via the MEK/ERK/c-Myc Pathway
Harun Badakhshi
BioMed Research International.2016;2019(3)237
[DOI]
6Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients during abiraterone/enzalutamide treatment
Cem Onal,Fatih Kose,Gokhan Ozyigit,Sercan Aksoy,Ezgi Oymak,Sadik Muallaoglu,Ozan C. Guler,Burak Tilki,Pervin Hurmuz,Fadil Akyol
The Prostate.2021;81(9)543
[DOI]
7Combining abiraterone and radiotherapy in metastatic castration-resistant prostate cancer: a review of current evidence
Lorenzo Livi,Beatrice Detti,Giulio Francolini,Francesca Terziani,Luca Triggiani,Rolando M. D’Angelillo,Gianluca Ingrosso
Tumori Journal.2019;105(4)277
[DOI]
Feedback

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal